Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Search tool

Displaying 1 - 18 of 18

News

New multi-city syringe study uncovers latest patterns of injecting drug use

17.02.2021

The latest patterns of injecting drug use in a selection of European cities are explored today in a new study from the EMCDDA.

News

Maximising access to drug treatment while minimising diversion of medications — new EMCDDA report looks at striking the balance

11.02.2021

Opioid substitution treatment (OST) is a key evidence-based tool used to manage opioid dependence and improve related health and social consequences. Yet increasing reports of the diversion and misuse of the controlled drugs used in this treatment in Europe are a cause for concern.

News

COVID-19 disruption and a strong drug market bring new threats to health and security in Europe

22.09.2020

High availability across all drug types, drug production within Europe and highly potent substances are among the concerns addressed today by the EU drugs agency (EMCDDA) in its European Drug Report 2020: Trends and Developments (1).

News

New report highlights wide-ranging impacts of EU drug markets on health and security

26.11.2019

Europeans are spending at least EUR 30 billion on drugs each year at retail level, making the drug market a major source of income for organised crime groups in the European Union.

News

Drug overdoses can be prevented — new resources released

30.08.2019

Latest estimates show that drug overdose deaths in Europe have risen for the fifth consecutive year, with a record 9 461 lives lost in 2017 (EU 28, Turkey and Norway). Reducing drug-related deaths is therefore a major public health challenge.

News

Latest update on drug-related deaths and mortality in Europe

30.07.2019

The EMCDDA has published today its latest update on Drug-related deaths and mortality in Europe. The information provided in the report is collected through the EMCDDA’s expert network on drug-related deaths (DRD)

News

61st Commission on Narcotic Drugs, 12-18 March 2018, Vienna

26.02.2018

The United Nations Commission on Narcotic Drugs (CND), the central UN policy-making body on drug-related matters, holds its 61st session in Vienna from 12–18 Mar

News

Preventing and reducing drug overdoses — a priority for the EMCDDA

30.08.2017

International Overdose Awareness Day is an annual event, held on 31 August, to raise awareness of overdose and reduce the stigma of drug-related death. The EMCDDA marks the day by highlighting its latest figures on overdose deaths in Europe and expressing support for interventions that prevent such...

News

#WorldHepatitisDay: EMCDDA joins forces with partners to address viral hepatitis elimination targets

28.07.2017

Every year, on 28 July, the World Health Organization (WHO) and partners mark World Hepatitis Day (WHD) to increase awareness and understanding of viral hepatitis and the diseases it causes. Read news item and the latest edition of Drugnet Europe for more on this topic.

News

EMCDDA and ECDC join forces to address the challenge of hepatitis

12.06.2017

Hepatitis and other drug-related infectious diseases will be the focus of ‘Hepatitis week’, taking place at the EMCDDA in Lisbon from 12–16 June. The initiative brings together some 100 specialists in the field and features a joint day with ECDC.

News

EMCDDA highlights growing threats posed by new and established substances

06.06.2017

Rising overdose deaths, the availability of new psychoactive substances and the growing health threat of potent synthetic opioids are among the issues highlighted in this year's European Drug Report.

News

New EMCDDA report shows grounds for hope in treating hepatitis C

28.07.2016

Hepatitis C is an infectious disease of the liver caused by the blood-borne hepatitis C virus. In a new report published today on World Hepatitis Day, the EU drugs agency (EMCDDA) looks at new opportunities for the effective prevention and treatment of hepatitis C.

News

EMCDDA highlights new health risks as products and patterns of use change

31.05.2016

Europe’s drug market remains resilient, says the EU drugs agency (EMCDDA) today as it launches in Lisbon its European Drug Report 2016: Trends and Developments,

News

New EMCDDA insights into naloxone, the overdose antidote that can help save lives

18.01.2016

Between 6 000 and 8 000 drug-induced deaths are reported in Europe every year, with opioids, such as heroin, found in most overdose cases. Yet with adequate intervention, using the overdose-reversal drug naloxone, many of these deaths can be prevented.

News

New EMCDDA report explores combined mental health and substance use disorders

27.11.2015

The co-existence of mental illness and psychoactive drug or other substance use problems — otherwise known as ‘comorbidity’ or ‘dual diagnosis’ — is an issue which has been on the radar of the EU drugs agency (EMCDDA) for over a decade (1).

News

4,4'-DMAR and MT-45 to be placed under control across the EU

20.10.2015

Europe has responded to rising concerns over the use of two new drugs by subjecting them to ‘control measures and criminal penalties’ throughout the Union.

News

Pregnancy and opioid use: strategies for treatment

14.11.2014

Illicit opioid consumption is associated with an increase in obstetric complications in pregnant women. It also brings with it a range of potential dangers for the child, both before and after birth.

News

Four new drugs to be placed under control

25.09.2014

Today, EU Ministers adopted a European Commission proposal to control four new psychoactive substances currently raising health concerns in Europe.
Loading